| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 12/13/2001 | WO2001094377A2 Metalloprotease peptide substrates and methods |
| 12/13/2001 | WO2001093893A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/13/2001 | WO2001034171A3 Peptides for treatment of erectile dysfunction |
| 12/13/2001 | WO2001027136A3 Peptides which stimulate the immune response and tissue regeneration |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2000029009A9 Peptides having anti-cancer and anti-inflammatory activity |
| 12/13/2001 | CA2414061A1 Metalloprotease peptide substrates and methods |
| 12/13/2001 | CA2411067A1 Oligopeptides for promoting hair growth |
| 12/13/2001 | CA2398277A1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 12/12/2001 | EP1162206A2 Peptide nucleic acids |
| 12/12/2001 | EP1161957A1 Complex for transferring an anionic substance of interest into a cell |
| 12/12/2001 | EP1161522A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 12/12/2001 | EP1161450A1 Bone stimulating factor |
| 12/12/2001 | EP1161449A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/12/2001 | EP1161149A1 Ng2/hm proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0750610B1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |
| 12/12/2001 | EP0670751B1 Improved sensor membranes |
| 12/12/2001 | EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/12/2001 | EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| 12/11/2001 | US6329506 Template-assisted triple helical collagen-like structures |
| 12/11/2001 | US6329502 Viricides against human immunodeficiency virus; treatment of aids (acquired immune deficiency syndrome) |
| 12/11/2001 | US6329501 Methods and compositions for targeting compounds to muscle |
| 12/11/2001 | US6329498 Amino acid sequence; stable preparation for treatment of human immunodeficiency virus |
| 12/11/2001 | US6329497 Sandramycin analogs |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6329336 Glue and crosslinking agent using albumin |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092333A2 Use of adnf for enhancing learning and memory |
| 12/06/2001 | WO2001092312A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001092292A2 Ghrelin analogs |
| 12/06/2001 | WO2001092290A2 Ganesin, an 18-residue cysteine-rich defense peptide from spider and related antinicrobial papdides, their preparation and uses. |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001052875A8 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410735A1 Use of adnf for enhancing learning and memory |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2409964A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159296A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 12/05/2001 | EP1159294A1 Carbohydrate epitope mimic peptides and uses thereof |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159288A1 Alpha-conotoxin peptides |
| 12/05/2001 | EP0751954B1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 12/05/2001 | EP0605432B1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 12/05/2001 | CN1325376A Novel compounds and medicinal use thereof |
| 12/04/2001 | US6326467 Peptide hormones, lh-rh |
| 12/04/2001 | US6326352 Compounds and methods for modulating cell adhesion |
| 12/04/2001 | US6326200 Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof |
| 12/04/2001 | CA2278883C Very large scale immobilized peptide synthesis |
| 12/04/2001 | CA2046880C Substituted alkylamide derivatives of teicoplanin |
| 12/01/2001 | CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof |
| 11/29/2001 | WO2001090194A2 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 11/29/2001 | WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 11/29/2001 | WO2001090153A2 Reagents for cell selection and methods of use |
| 11/29/2001 | WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents |
| 11/29/2001 | WO2001089551A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 11/29/2001 | WO2001089286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 11/29/2001 | WO2001044272A3 Daptomycin analogs as antibacterial agents |
| 11/29/2001 | WO2001038347A3 Peptides having antiangiogenic activity |
| 11/29/2001 | WO2001034095A8 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 11/29/2001 | US20010046498 Chimeric prostate-homing peptide comprising a sequence of serine-methionine-serine-isoleucine-alanine-arganine-leucine, or functionally equivalent sequence |
| 11/29/2001 | DE10023743A1 Peptidsubstrate zur direkten Messung enzymatischer Aktivitäten Peptide substrates for the direct measurement of enzymatic activities |
| 11/29/2001 | CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents |
| 11/28/2001 | EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms |
| 11/28/2001 | EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 11/28/2001 | EP1157030A1 Echinocandin/carbohydrate complexes |
| 11/28/2001 | EP1156823A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 11/28/2001 | EP1156817A1 Controlling protein levels in eucaryotic organisms |
| 11/28/2001 | EP1156816A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans |
| 11/28/2001 | EP1032588A4 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 11/28/2001 | EP0853483A4 Novel peptides |
| 11/28/2001 | EP0804469B1 T-cell affecting peptides |
| 11/28/2001 | EP0804215B1 Template assembled synthetic protein |
| 11/28/2001 | CN1324367A Cyclic prosaposin-derived peptides and uses thereof |
| 11/28/2001 | CN1324258A Aglyco products and method of use |
| 11/28/2001 | CN1075512C Synthetic peptide reagent for detecting coxsackie B-group virus anti-body |
| 11/27/2001 | US6323315 For therapy of cancer |
| 11/27/2001 | US6323179 Chicken GNRH analogs and uses thereof in regulation of fertility and pregnancy |
| 11/27/2001 | US6323176 Cyclic peptide antifungal agents |
| 11/27/2001 | US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses |
| 11/27/2001 | US6322964 Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies |
| 11/27/2001 | US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18 |